Robert H. Spencer

3.0k total citations · 1 hit paper
54 papers, 2.3k citations indexed

About

Robert H. Spencer is a scholar working on Molecular Biology, Physiology and Dermatology. According to data from OpenAlex, Robert H. Spencer has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Physiology and 9 papers in Dermatology. Recurrent topics in Robert H. Spencer's work include Ion channel regulation and function (16 papers), Dermatology and Skin Diseases (9 papers) and Aerodynamics and Acoustics in Jet Flows (7 papers). Robert H. Spencer is often cited by papers focused on Ion channel regulation and function (16 papers), Dermatology and Skin Diseases (9 papers) and Aerodynamics and Acoustics in Jet Flows (7 papers). Robert H. Spencer collaborates with scholars based in United States, Germany and Australia. Robert H. Spencer's co-authors include Douglas C. Rees, Geoffrey Chang, Allen T. Lee, László Kiss, Stefanie A. Kane, Wei Zheng, Aaron C. Overland, Michael R. Vasko, Todd W. Vanderah and Christoph Stein and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Robert H. Spencer

51 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the MscL Homolog from Mycobacterium tuberculosis : A Gated Mechanosensitive Ion Channel

1998 820 citations Geoffrey Chang, Robert H. Spencer et al. Science profile →

Peers

Countries citing papers authored by Robert H. Spencer

Since Specialization

Citations

This map shows the geographic impact of Robert H. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Spencer more than expected).

Fields of papers citing papers by Robert H. Spencer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Spencer. The network helps show where Robert H. Spencer may publish in the future.

Co-authorship network of co-authors of Robert H. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Spencer. A scholar is included among the top collaborators of Robert H. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Spencer. Robert H. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus 2024 ·BMC Nephrology ·Robert H. Spencer, Patrick K. Noonan, Thomas Marbury, Frédérique Menzaghi	2
2	Assessment of the physical dependence potential of difelikefalin: Randomized placebo‐controlled study in patients receiving hemodialysis 2023 ·Clinical and Translational Science ·Robert H. Spencer, Catherine Munera, Megan J. Shram, Frédérique Menzaghi	6
3	A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus 2023 ·Journal of the American Academy of Dermatology ·Gil Yosipovitch, (unknown), Robert H. Spencer, Catherine Munera, Frédérique Menzaghi	17
4	The Burden of Pruritus Associated With CKD: A Mixed Methods Analysis Among Patients Undergoing Dialysis 2023 ·Kidney Medicine ·Frédérique Menzaghi, Margaret Vernon, (unknown), (unknown), Warren Wen, Robert H. Spencer, Catherine Munera	5
5	Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis 2023 ·Clinical Pharmacokinetics ·Jeffrey G. Stark, Patrick K. Noonan, Robert H. Spencer, (unknown), Stephen J. O’Connor, Frédérique Menzaghi	7
6	Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus 2021 ·Journal of Patient-Reported Outcomes ·Margaret Vernon, (unknown), Rebecca M. Speck, Catherine Munera, Robert H. Spencer, Warren Wen, Frédérique Menzaghi	20
7	(422) CR845, a peripheral kappa opioid, provides better pain relief with less nausea and vomiting than placebo in patients after bunionectomy 2015 ·Journal of Pain ·Frédérique Menzaghi, Robert H. Spencer, (unknown), (unknown), Derek Chalmers	12
8	Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3) 2011 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk, Ronald K. Chang, Christina N. Di Marco, Robert M. DiPardo, Sean P. Cook, Matthew J. Cato, Aneta Jovanovska, Mark O. Urban, Michael Leitl, Robert H. Spencer, Stefanie A. Kane, George D. Hartman, Mark T. Bilodeau	16
9	Reversal of acid‐induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2 2010 ·British Journal of Pharmacology ·Jerzy Karczewski, Robert H. Spencer, Victor M. Garsky, (unknown), Michael Leitl, Matthew J. Cato, Sean P. Cook, Stefanie A. Kane, Mark O. Urban	108
10	Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel 2010 ·Bioorganic & Medicinal Chemistry Letters ·Douglas C. Beshore, Nigel J. Liverton, Charles McIntyre, Christopher F. Claiborne, Brian E. Libby, Joseph Culberson, Joseph J. Salata, Christopher P. Regan, Joseph J. Lynch, László Kiss, Robert H. Spencer, (unknown), Rebecca B. White, Suzie Yeh, George D. Hartman, Christopher J. Dinsmore	12
11	Synthesis, Structure−Activity Relationship, and Pharmacological Profile of Analogs of The ASIC-3 Inhibitor A-317567 2009 ·ACS Chemical Neuroscience ·Scott D. Kuduk, Christina N. Di Marco, (unknown), Sean P. Cook, Matthew J. Cato, Aneta Jovanovska, Mark O. Urban, Michael Leitl, (unknown), (unknown), Robert H. Spencer, Stefanie A. Kane, George D. Hartman, Mark T. Bilodeau	33
12	High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5 2008 ·Biochemical Pharmacology ·Jerzy Karczewski, Laszlo Kiss, Stefanie A. Kane, Kenneth S. Koblan, Robert J. Lynch, Robert H. Spencer	11
13	Potent antagonists of the Kv1.5 potassium channel: Synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·Kausik K. Nanda, (unknown), Matthew J. Cato, Stefanie A. Kane, László Kiss, Robert H. Spencer, Jixin Wang, Joseph J. Lynch, Christopher P. Regan, Gary L. Stump, Bing Li, Rebecca B. White, Suzie Yeh, Michael J. Bogusky, Mark T. Bilodeau, Christopher J. Dinsmore, Craig W. Lindsley, George D. Hartman, S. E. Wolkenberg, B. Wesley Trotter	11
14	TBX5 Genetic Testing Validates Strict Clinical Criteria for Holt-Oram Syndrome 2005 ·Pediatric Research ·Deborah A. McDermott, Michael Bressan, Jié He, Joseph S. Lee, Salim Aftimos, Martina Brueckner, Fiona J. Gilbert, Gail E. Graham, Mark Hannibal, Jeffrey W. Innis, Mary Ella Pierpont, Annick Raas‐Rothschild, Alan Shanske, Wendy E. Smith, Robert H. Spencer, Martin G. St. John-Sutton, Lionel Van Maldergem, Darrel Waggoner, Matthew P. Weber, Craig T. Basson	104
15	High Throughput Assay Technologies for Ion Channel Drug Discovery 2004 ·Assay and Drug Development Technologies ·Wei Zheng, Robert H. Spencer, László Kiss	90
16	Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy 2000 ·Medical Physics ·Michael G. Stabin, Mark Konijnenberg, F.F. Knapp, Robert H. Spencer	22
17	Crystallographic Analyses of Ion Channels: Lessons and Challenges 2000 ·Journal of Biological Chemistry ·Douglas C. Rees, Geoffrey Chang, Robert H. Spencer	38
18	Structure of the MscL Homolog from Mycobacterium tuberculosis : A Gated Mechanosensitive Ion Channel breakdown → 1998 ·Science ·Geoffrey Chang, Robert H. Spencer, Allen T. Lee, (unknown), Douglas C. Rees	820
19	Purification, Visualization, and Biophysical Characterization of Kv1.3 Tetramers 1997 ·Journal of Biological Chemistry ·Robert H. Spencer, Yuri Sokolov, Huilin Li, (unknown), Anthony J. Milici, Jayashree Aiyar, Angela Nguyen, (unknown), Bing K. Jap, James E. Hall, George A. Gutman, K. George Chandy	49
20	Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus. 1988 ·The Journal of Immunology ·(unknown), K. George Chandy, Robert H. Spencer, Sudhir Gupta, P K Pattengale, H Fan	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact